icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
5-year Entecavir treatment in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety profile but no prevention of HCC in cirrhotics
 
 
  Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
 
P. Lampertico1*, R. Soffredini1, M. Vigaṇ2, E. Minola3, G. Cologni4, M. Rizzi4, S. Zaltron5, A. Vavassori5, F. Castelli5, E. Angeli6, G.A. Gubertini6, C. Magni6, G. Rizzardini6, A. Testa7, G. D'Offizi7, M. Vinci8, G. Pinzello8, E. Fatta9, S. Fargion9, S. Colombo10, O. Fracassetti10, P. Del Poggio11, B. Coco12, M.R. Brunetto12, M. Andreoletti13, A. Colli13, M. Fasano14, T. Santantonio15, G. Colloredo16, L. Pasulo17, S. Fagiuoli17, A.E. Colombo18, G. Bellati18, M. Milanese19, M. Strazzabosco19, M. Pozzi20, N. Terreni21, G. Spinzi21, M. Quagliuolo22, M. Borzio22, G. Lunghi23, F. Facchetti1, F. Invernizzi1, M. Colombo1

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif